🇺🇸 FDA
Patent

US 8524248

Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

granted A61KA61K2039/5258A61P

Quick answer

US patent 8524248 (Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/5258, A61P, A61P31/20, A61P35/00